Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models

Obesity and type 2 diabetes mellitus (T2DM) are preconditions for the development of metabolic syndrome, which is reaching pandemic levels worldwide, but there are still only a few anti-obesity drugs available. One of the promising tools for the treatment of obesity and related metabolic complicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mráziková, Lucia, Neprašová, Barbora, Mengr, Anna, Popelová, Andrea, Strnadová, Veronika, Holá, Lucie, Železná, Blanka, Kuneš, Jaroslav, Maletínská, Lenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637538/
https://www.ncbi.nlm.nih.gov/pubmed/34867411
http://dx.doi.org/10.3389/fphar.2021.779962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637538/
https://www.ncbi.nlm.nih.gov/pubmed/34867411
http://dx.doi.org/10.3389/fphar.2021.779962

Ejemplares similares